Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,108.06
(
-0.42%
)
US TECH 100
26,046.80
(
-0.60%
)
Dow Jones
49,303.42
(
-0.38%
)
Brent Oil
100.96
(
4.38%
)
Bitcoin
77,776.06
(
-0.59%
)
News Focus
News Focus
Post# of 438
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DanWebzster

Send PM Follow Ignore
Followers 10
Posts 1063
Boards Moderated 2
Alias Born 09/04/2000

DanWebzster

Member Level

Re: DanWebzster post# 286

Thursday, 08/09/2018 8:33:20 AM

Thursday, August 09, 2018 8:33:20 AM

Post# of 438
LQDA is a recent IPO with a 5% ownership stake by Gates Foundation.

Lead candidate will have Ph3 results during H1/19

Technological edge would be their PRINT platform for producing uniform drug particles.

LIQ861 is an inhalant PAH treatment aimed at reducing off target effects. TAM = ~$1.2Bn MNKD's Tre-T is a competing product.

LIQ865 for post-operative pain will enter Ph2 trial Q4/18

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today